Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
D Galun, Tatjana Srdić‐Rajić, Aleksandar Bogdanović, et al.
Journal of Hepatocellular Carcinoma (2017) Vol. Volume 4, pp. 93-103
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
Lu Chen, Dawei Rong, Betty Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 364
The Role of MicroRNAs in Hepatocellular Carcinoma
Xin Xu, Yuquan Tao, Liang Shan, et al.
Journal of Cancer (2018) Vol. 9, Iss. 19, pp. 3557-3569
Open Access | Times Cited: 157
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy
Yongbing Sun, Wen Ma, Yuanyuan Yang, et al.
Asian Journal of Pharmaceutical Sciences (2019) Vol. 14, Iss. 6, pp. 581-594
Open Access | Times Cited: 107
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Renyu Zhang, Wei Ding, Ze-Kun Liu, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 81
Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma
Yong Han, Yanli An, Gang Jia, et al.
Nanoscale (2018) Vol. 10, Iss. 14, pp. 6511-6523
Closed Access | Times Cited: 79
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
Flavia Fondevila, Carolina Méndez‐Blanco, Paula Fernández‐Palanca, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 9, pp. 1-15
Open Access | Times Cited: 75
Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity
Zhen Tao, Hailong Ruan, Lin Sun, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1135-1147
Open Access | Times Cited: 63
TRP Channels in Digestive Tract Cancers
Paulina Stokłosa, Anna Borgström, Sven Kappel, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1877-1877
Open Access | Times Cited: 52
Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78
Zhiwen Gu, Lei Wang, Qian Dong, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 29
Open Access | Times Cited: 20
Adoptive cell transfer therapy for hepatocellular carcinoma
Renyu Zhang, Zhao Zhang, Zekun Liu, et al.
Frontiers of Medicine (2019) Vol. 13, Iss. 1, pp. 3-11
Open Access | Times Cited: 53
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Samrat Chakraborty, Zewdu Yilma, Somdyuti Chakraborty, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 34-49
Open Access | Times Cited: 50
Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
Chendong Yang, Aihua Hou, Chunfeng Yu, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 983-996
Open Access | Times Cited: 47
Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway
Mingxia Lu, Zhenghua Fei, Ganlu Zhang
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 1282-1288
Closed Access | Times Cited: 46
The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma
Yide Huang, Yafei Zhang, Lilin Ge, et al.
Cancers (2018) Vol. 10, Iss. 3, pp. 82-82
Open Access | Times Cited: 39
Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer
Ching-Ying Chen, Sheng‐Ming Wu, Yang-Hsiang Lin, et al.
Theranostics (2019) Vol. 9, Iss. 8, pp. 2361-2379
Open Access | Times Cited: 37
HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
Junhua Li, Wei Zhou, Qiang Mao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
<p>IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma</p>
Yuan Liu, Jing-Jing Zhao, Zi-Qi Zhou, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 6691-6702
Open Access | Times Cited: 26
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Robin Park, Fariha Eshrat, Mohammed Al‐Jumayli, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 447-447
Open Access | Times Cited: 26
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 129, pp. 44-53
Closed Access | Times Cited: 27
Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells
Qingqing Xiong, Mangmang Cui, Yu Ge, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 24
RETRACTED: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
Yunchao Xu, Xu Liu, Min Li, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 578-590
Open Access | Times Cited: 24
Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR‐625‐3p/PDLIM5 pathway
Jinyi Wang, Yong Zhu, Xiaoming Ai, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 8
Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model
Min Hee Yang, Mina Lee, Amudha Deivasigamani, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4681-4681
Open Access | Times Cited: 8
Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
K Nagai, Baasanjav Uranbileg, Zhen Chen, et al.
Rapid Communications in Mass Spectrometry (2019) Vol. 34, Iss. S1
Open Access | Times Cited: 20
Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration
Yangyang Guo, Hengyue Zhu, Min Weng, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 128, pp. 110366-110366
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top